UK biotech F2G has raised $100 million as it prepares to refile its olorofim candidate for invasive fungal infections, which was turned down last year by the FDA. The Manchester-based company said ...

An often-overlooked mechanism of gene regulation may be involved in the failure of antifungal drugs in the clinic, claims a ...

A man is worried his home might kill him after claiming black mould in the property hit him with a deadly fungal lung disease ...

Late-stage clinical investigation of ibrexafungerp for the treatment of life-threatening invasive fungal infections in hospitalized patients is ongoing. Additional antifungal assets from this ...

Vietnam Invasive Fungal Infection Market Key Takeaways: The Vietnam Invasive Fungal Infection (IFI) market is experiencing significant growth propelled by factors such as an increasing incidence of ...

Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with ...

Computer models developed by the University of Chicago and Argonne National Laboratory predict that hotter, drier conditions in North America will limit the growth of a fungus that normally curbs the ...

Geode Capital Management LLC increased its stake in SCYNEXIS, Inc. (NASDAQ:SCYX – Free Report) by 10.0% during the 3rd ...

the Company’s second-generation triterpenoid antifungal in development for the treatment of severe invasive fungal infections. “We are pleased to advance our potent, second-generation fungerp ...